Multiple Sclerosis is the most common inflammatory demyelinating disorder of central nervous system.
There are multiple groups of disease-modifying drugs with different mechanisms of action that are used for the treatment of MS.
Injectable DMTs including interferons and glatiramer acetate have been used for more than 2 decades for the treatment of MS and similar to any other medicines may lead to some adverse effects.
In this article, these side effects and monitoring of them will be discussed
Neurology Letters